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Abstract 
Background: Anxiety disorders are the most common mental health problem worldwide. 
However, the evidence on the association between anxiety disorders and risk of stroke is limited.  
This systematic review and meta-analysis presents a critical appraisal and summary of the 
available evidence on the association between anxiety disorders and risk of stroke. 
Methods: Cohort studies reporting risk of stroke among patients with anxiety disorders were 
searched in PubMed, Embase, PsycINFO, Scopus, and the Web of Science, from database 
inception to June 2016. The quality of the studies was assessed using standard criteria. A meta-
analysis was undertaken to obtain pooled estimates of the risk of stroke among patients with 
anxiety disorders.  
Results: Eight studies, including 950759 patients, from the 11764 references initially identified, 
were included in this review. A significantly increased risk of stroke for patients with anxiety 
disorders was observed, with an overall hazard ratio: 1.24 (1.09-1.41) p=0.001 No significant 
heterogeneity between studies was detected and the funnel plot suggested that publication bias 
was unlikely. Limited evidence suggests that the risk of stroke is increased shortly after the 
diagnosis of anxiety and that risk of stroke may be higher for patients with severe anxiety. 
Conclusions: Anxiety disorders are a very prevalent modifiable condition associated with risk of 
stroke increased by 24%. This evidence could inform the development of interventions for the 
management of anxiety and the prevention of stroke. Further studies on the risk of stroke in 
patients with anxiety, and the explanatory factors for this association, are required. 
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1. Introduction 
Anxiety disorders are the most common mental health problem worldwide with lifetime 
prevalence in the general population, varying across countries, up to 29%.(1-3) It is also the sixth 
global leading cause of disability, with no discernible change observed from 1990.(4) Stroke is 
the second most common cause of death, and the third most common cause of reduced disability-
adjusted life-years (DALYs), worldwide.(5, 6) Most of the burden of stroke affects low and 
middle-income countries.(7) Primary prevention of stroke is particularly important because 76% 
of strokes are first events.(8)  Anxiety disorders can have a direct effect on incidence of stroke 
and also an indirect effect as they may be associated with other cardiovascular risk factors and 
markers of high cardiovascular risk.(9, 10) While the association between anxiety disorders and 
coronary artery disease is well established,(11) their impact on the risk of stroke has received 
less attention. Previous reviews on the associations between anxiety and cardiovascular disease 
(12-17) do not present specific results for stroke, or do not include the most updated studies. A 
better understanding of the association between anxiety disorders and stroke would strengthen 
the evidence for causality and, since anxiety disorders are modifiable conditions, it could also 
inform the development of clinical and public health interventions for the management of 
anxiety and the prevention of stroke. This systematic review and meta-analysis presents an up to 
date critical appraisal and summary of the available evidence on the association between anxiety 
disorders and risk of incident stroke.  
 
2. Methods 
The Meta-analysis of Observational Studies in Epidemiology (MOOSE) criteria were used to 
undertake this review (Appendix A).(18) Electronic searches were conducted by three authors 
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(MPP, EG and LA) in PubMed, Embase, PsycINFO, Scopus and the Web of Science, from 
database inception to the 7th June 2016.  
We aimed to identify studies in compliance with the following inclusion criteria: 
1) Cohort study design  
2) Reporting of original research data 
3) Anxiety disorder assessed as exposure 
4) Incident strokes reported as outcome 
5) Direct reporting of relative risk (RR), odds ratio (OR), or hazard ratio (HR) with  
corresponding 95% confidence intervals (CIs), or sufficient raw data such that estimates  could 
be calculated.  
The search strategy is presented in appendix B. The titles and abstracts of all the references 
identified in the initial search were checked against inclusion criteria.  Papers citing all the 
included studies, or relevant reviews (12-17) were also searched in the Web of Science and 
considered for inclusion. The bibliography of all papers fitting the inclusion criteria and relevant 
reviews (12-17) was checked as well for further articles. There were no restrictions on the basis 
of language, sample size or duration of follow-up. Studies were excluded if they were:  
1) Limited to specific clinical outcomes (e.g. haemorrhagic stroke)  
2) Conducted in specific patient sub-populations (e.g. postmenopausal women)  
3) Reporting a composite outcome (e.g. stroke and coronary artery disease combined) unless 
separate results for stroke patients were identified. 
4) Cross sectional in design 
5) Studies with retrospective recruitment.  
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Authors of the studies were contacted in some cases, as similarities between articles indicated the 
possibility of multiple publications from the same cohort. Where several studies reported results 
from the same population, data were taken from the publication with the longest follow-up. Data 
were extracted from the included studies using a predefined template and the quality of each 
study was assessed using standard criteria (appendix C).(19) A meta-analysis was undertaken to 
obtain pooled estimates of the risk of stroke among patients with anxiety disorders. A random-
effect model was used to summarise the mean estimated effect (hazard ratio), obtained from the 
included studies and results were graphically presented in a forest plot.  The assumption made 
was that the size of the true effect varies from one study to the other, and that the studies 
considered in our analysis constitute a random sample of all possible effect sizes that could have 
been observed. The random-effect approach was considered preferable to the fixed-effect 
approach where the true effect size in the latter is assumed to be the same in all studies.(20) The 
heterogeneity between studies was measured using I-squared index that represents the percentage 
of the total variation which is due to differences between studies. Chi-squared statistic was used 
to test the significance of the heterogeneity.(21) When participants in the studies had been 
interviewed about symptoms of anxiety disorders at more than one time point, e.g. in the 
previous month and in the previous five years, the assessment referring to the time point closest 
to the date of study entry was included in the analysis as it was considered to be less affected by 
recall bias. When a study reported results from a multivariable model exploring the association 
between anxiety and stroke, and then further modeling had been conducted to explore potential 
explanatory factors for the association, only the results from the first model were included in the 
meta-analysis. When a study reported risk of stroke at one time point after the diagnosis of 
anxiety, and after examinations of the HRs for each year of follow up, an estimate of risk of 
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stroke at a different time point had also been calculated, data from the first estimate was included 
in the meta-analysis. A funnel plot was used to investigate possible publication bias, true 
heterogeneity and other methodological irregularities.(22) Sensitivity analyses were performed, 
first to exclude two studies, which differ in measures of anxiety and age categorization from the 
rest of the papers,(23, 24) one at a time and simultaneously, and second, to exclude one study 
with very large variance,(25) to examine the impact of each exclusion on the pooled estimate and 
on the heterogeneity of the studies included. 
 
3. Results: 
The electronic and hand searches identified 11764 references, six of which were reviews relevant 
to the topic.(12-17) A total of 46 full text studies were assessed for inclusion. Finally, eight 
studies were considered to comply with inclusion criteria and were included in this review 
(Figure one). The characteristics of these studies are presented in table one. All of them were 
considered to be of high quality (Appendix C),(19) they were all population based, and included 
a total of 950759 patients.(23-30) Three studies had been conducted in the USA, two in the UK, 
one in Canada, one in Taiwan, and another one in The Netherlands. Three of them used medical 
records,(26, 27, 29) and five included participants from epidemiological surveys.(23-25, 28, 30) 
Six studies included patients with all types of anxiety disorders, in one study participants were 
examined specifically for generalised anxiety disorder,(25) and in another one for panic 
disorder.(27) The identification of patients with anxiety disorders was conducted in two studies, 
(26, 27) with DSM III, DSM IV, and  ICD-9 criteria,(31-33) another five studies used scales,(23-
25, 28, 30) and diagnoses recorded in primary care notes were used in another study.(29)  The 
follow up time ranged from ten to 22 years and the proportion of incidents strokes observed 
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ranged from 0.2 to 12.6% with larger proportions of strokes observed in studies with longer 
follow up.(28, 30) Three studies excluded patients with past medical history of stroke,(25, 28, 
29) two excluded patients with history of stroke in the year before study entry,(26, 27) and one 
excluded those with past medical history of cardiovascular disease.(24) The eight papers studied 
potential associations between anxiety and all types of strokes. One study observed only the 
association between anxiety and non-fatal strokes.(29) Another one reported the associations of 
anxiety with all types of strokes, and specifically with ischaemic strokes, which were not 
significant in either analyses.(30) 
Three papers reported a significantly increased risk of stroke in patients with anxiety,(26-28) out 
of which one study reported also a dose–response relation, with a 17% increased risk of stroke 
for every standard deviation increase in anxiety.(28) A significantly increased pooled risk of 
stroke for patients with anxiety disorders was observed, with an overall hazard ratio (HR) 
estimated from the meta-analysis: 1.24 (95% CI: 1.09-1.41) p=0.001 (Figure two). Heterogeneity 
between studies was low and not significant, I-squared index was 26.7% (p=0.216).(21) 
Sensitivity analysis excluding the studies by Vogt and colleagues,(23) Stewart and 
colleagues,(24) and  both at the same time, only altered the magnitude of the pooled estimate by 
a negligible amount and the heterogeneity remained insignificant.  The removal of the study by 
Surtees and colleagues(25) increased the heterogeneity to I-Squared 29.7%, but had negligible 
impact on the pooled estimate and its 95% confidence intervals. The funnel plot demonstrated a 
reasonable symmetry suggesting that publication bias, and other sources of biases due to 
methodology, quality, and small studies effect are unlikely (Figure three).  
In two papers, after examination of the HRs for each year of follow up, the time between 
symptoms of anxiety and risk stroke was investigated. One of them reported an increased risk of 
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stroke only within three years of the detection of anxiety, HR: 2.55 (1.45–4.46) but not in the 
longer term.(30) The other paper did not find an association between anxiety and stroke but 
reported an increased risk for cardiovascular disease (myocardial infarction or stroke) within 
three years of the detection of anxiety, but not in the longer term (24) They both suggest a 
possible short-term effect for anxiety symptoms on the risk of stroke.  
Three papers explored the role of cardiovascular risk factors in the association between anxiety 
and stroke (28-30) Only one of them observed an association between anxiety and stroke, which 
became weaker but remained significant after adjusting for blood pressure, cholesterol, diabetes 
mellitus, body mass index, alcohol use, physical activity, smoking, and antihypertensive 
medication, in a multivariable model.(28)  
Three papers explored the role of depression in the association between anxiety and stroke. In all 
three the risk of stroke was not increased for patients with anxiety and this did not change when 
depression was included in the models.(24, 29, 30) None of the studies included in this review 
explored biological explanatory factors for the association between anxiety and stroke, such as 
inflammatory markers. 
 
4. Discussion 
The risk of stroke among patients with anxiety disorders has been investigated in a limited 
number of cohort studies, which were considered to be of good quality. The meta-analysis 
provides strong evidence for an association between anxiety and stroke, with a pooled risk of 
stroke increased by 24% among patients suffering anxiety disorders. There is limited evidence 
suggesting that the risk of stroke may be higher within three years of the diagnosis of anxiety, 
and that the risk of stroke may be further increased for patients with severe anxiety.  
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The evidence on the explanatory factors for the association between anxiety disorders and stroke 
is still limited. The increased prevalence of cardiovascular risk factors observed in patients with 
anxiety disorders may explain their higher risk of stroke (9, 34, 35) However, the only study that 
reported a significant association between anxiety and stroke, and adjusted at a later stage for 
cardiovascular risk factors, reported that the association became weaker but remained 
significant.(28) This suggests that cardiovascular risk factors do not fully explain the increased 
risk of stroke among patients with anxiety disorders. Therefore, a biological link between 
anxiety and stroke could also be considered. This would include the association of anxiety 
disorders with abnormal heart rhythm, raised inflammatory markers, dysfunctions of the 
hypothalamic pituitary adrenal axis, and an increased risk of developing carotid plaques or 
arterial stiffness. Persistent estates of anxiety induce a hypothalamic-pituitary-adrenal 
hyperactivity with continuous sympathetic nervous system activation. The elevation of several 
neuropeptides results in a high blood pressure and arrhythmias, and the release of cytokines has 
pro-inflammatory and pro-coagulant effects on endothelium. The persistent high levels of 
cortisol may also lead to a downregulation of the hypothalamic pituitary adrenal axis and 
contribute to abnormal lipid profiles.(10, 36-39)  
The lack of significant association between anxiety and stroke, observed in five papers, may be 
related to the long follow up of these studies. The association may be underestimated by the 
observation of patients long time after the diagnosis of anxiety, when the risk of stroke may not 
be increased.   
The results of this review are consistent with a retrospective multicentre study which reported 
that psychosocial stress was associated with high risk of stroke.(40) This systematic review 
builds on a previous article (16) that using a different inclusion criteria, reported an association 
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between anxiety and stroke across a number of papers, not including four recent studies which 
observed over half a million patients.(24, 28-30)  
The different measures of anxiety used across the studies may have affected the final results. 
The DSM criteria, used in two studies, is considered the gold standard to diagnose anxiety.(41) 
The scales used in three studies (24, 25, 30) were all validated against the DSM criteria.(41, 42) 
The scales used in another two studies (23, 28) were also specifically developed to measure 
anxiety disorders.(28, 43) Finally, the study that used medical records to categorize participants 
as anxiety patients was based in the UK, where the national guidelines recommend the use of a 
scale that has also been validated against DSM citeria.(44, 45) Therefore, in all eight studies the 
diagnosis of anxiety was assisted with a diagnostic tool, which gives, according to a recent 
systematic review, a sensitivity 67% and specificity of 88%.(46) The proportion of patients 
wrongly categorized may have resulted in an underestimation of the risk between anxiety and 
stroke, which could be stronger than the one observed.   
This review has some limitations. The diversity of the methods across studies, including the 
different statistical management, may have an effect on the external validity of each individual 
one. Furthermore, only one person extracted most of the data (MPP). Even so, all data were 
checked for accuracy on multiple occasions. The availability of only eight studies represents 
another limitation of this review. This study has some strengths as well. The comprehensive 
search and critical assessment of studies conducted in this review allows estimation of the 
association between anxiety disorders and stroke obtained on a large number of patients. The 
use of a random effect model based on the assumption that studies were independently 
conducted and do not necessarily share a common effect size, allowing  for more uncertainty of 
the final summary estimate was a conservative choice. The overall estimate remained significant 
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despite the increased width of the confidence intervals, providing support to the significance of 
the findings. The reasonably symmetrical funnel plot supports the theory that there is no 
publication bias.  While this is re-assuring, the plots may  also be used to assess “small study 
effects”, where smaller studies in a meta-analysis tends to show larger effects.(47)  Although all 
the studies included were large, nonetheless they do vary in size. The funnel plot highlighted the 
random distribution of the estimates, indicating that large effects were not associated with 
smaller studies.  
 
5. Conclusion 
Clinicians should consider the relevance of anxiety disorders, which are not only a distressing 
problem on their own, but also a predictors of coronary artery disease,(11) and stroke. Many 
patients have little understanding of the association between anxiety and physical disease,(48) 
therefore clinicians may have to highlight this link to help patients understand the clinical 
relevance of anxiety disorders. Given the high prevalence of anxiety disorders,(1-3) the 
magnitude of their association with major cardiovascular events, and provided that they are a 
treatable conditions, interventions on anxiety disorders should have a positive impact on the 
incidence of both coronary artery disease and stroke. 
Future studies on the risk of stroke in patients with anxiety disorders, and the explanatory 
factors for this association, are required in order to confirm, modify and/or expand these results. 
It is not possible to differentiate, with the available evidence, the risk of stroke associated with 
different anxiety disorders which may not be similar for panic disorders, agoraphobia, or other 
anxiety disorders. Therefore, the association between the different types of anxiety disorders, of 
different degrees of severity, and stroke, remains a matter for further research. Future studies 
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may also address the impact of anxiety disorders, on specific types of stroke, which may vary 
for ischaemic and haemorrhagic ones. All these studies are needed to develop effective clinical 
and public health interventions for the treatment of anxiety disorders and the prevention of 
stroke. While a long follow up is normally considered a strength of observational research, 
future studies may look at stokes within three years of the diagnosis of anxiety, which seems to 
be the moment of highest risk.(24, 30)  
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 Vogt  
1994 
Bowen 
2000 
Surtees 
2008 
Chou  
2012 
Lambiase 
2014 
Mathur 
2015 
Portegies 
2016 
Stewart 
2016 
Country USA Canada UK Taiwan USA UK The Ne-
therlands 
USA 
Data 
source 
Epidemiol
ogical 
Medical 
records 
Epidemio
logical 
Medical 
records 
Epidemio
logical 
Medical 
records 
Epidemio
logical 
Epidemio
logical 
N 1529 2657 20627 390309 6019 524952 2625 2041 
Age  ≥18 >15 41 to 80 ≥20 25-74 ≥20 ≥45 ≥60 
Female % 54 59  57 46 54 47 55 73 
Follow-up 15 years 12 years 12 years 10 years 22 years 10 years 20 years 9 years 
Anxiety 
assessmen
t  
Bradburn 
Worries 
Index 
ICD-9 
DSM-III 
DSMIIIR 
Health & 
Life 
Experienc
e (GAD)a 
ICD-9 
DSM-IV 
TR (PD) b 
General 
Wellbein
g scale 
Primary 
care  
records 
Hospital 
Anxiety 
Depressio
n scale 
Patient 
Questionn
aire  
Anxiety N 817 866 NR 1725 1953  22128  343 849 
Stroke 
assessmen
t  
ICD-7 ICD-9 ICD-9  
ICD-10 
ICD-9 ICD-9  Medical 
records 
Medical 
records  
ICD-9 
ICD-10 
Stroke n 
(%) 
Not 
reported 
44  
(1.6) 
595  
(2.9) 
19148 
(4.9) 
419 
(7.0) 
987  
(0.2) 
332 
(12.6) 
235 
(11.5) 
Adjustmen
t for 
covariates 
Age, sex, 
smoking, 
Health 
status, 
SES c 
Duration 
of health 
plan 
membershi
p 
Age sex Age sex 
CV Risk 
factors d   
SES c 
Pmhe:MI  
Fhf stroke 
Antidepre
-ssant use 
Age sex 
Comorbi-
dities 
Regular 
medicatio
n 
Age sex 
Ethnic. 
Education 
Marital 
status 
 
Age sex 
Ethnic. 
Age sex Age sex 
Ethnic.  
CV Risk 
factors d   
Hazard 
Ratio (CI) 
0.91  
(0.63-1.33) 
2.00  
(1.09-
3.64)  
0.81  
(0.33-
1.98)   
1.38  
(1.12-
1.71) 
1.43  
(1.14-
1.80)  
1.17  
(0.91-
1.51) 
1.06  
(0.76-
1.48) 
1.20  
(0.92-
1.56) 
 
Table 1. Characteristics of the studies included in this review. a- GAD: Generalised anxiety 
disorder, b- PD: Panic disorder, c- SES: Socioeconomic Status, d- CV Risk factors: Blood 
pressure , cholesterol, diabetes, smoking, obesity. e- PMH: Past medical history, f- FH: Family 
history 
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Figures titles: 
Figure 1: Results of literature search 
Figure 2: Pooled risk of stroke in patients with anxiety disorders 
Figure 3: Funnel plot of studies included in the review 
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